Nutritional SupplementationEarly Phase 1NCT06714331
Caffeine and Sodium Bicarbonate Supplementation Effects on Resistance Training Performance
A Early Phase 1 study testing Supplements in people with Nutritional Supplementation and Resistance Training, run by Memorial University of Newfoundland at 1 site in Canada.
Trial summary
This research aims to explore the effects of two supplements, caffeine and sodium bicarbonate, on acute (short-term) resistance training performance. The present study aims to assess the effects of caffeine and sodium bicarbonate supplementation on the number of repetitions, muscle activation, speed of movement, and… Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Nutritional Supplementation, Resistance Training
- What is being tested?
- Supplements
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 12 participants
- Where
- 1 siteCanada
- Study dates
- 1 Aug 2024to 5 May 2025
- Phase
- Early Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- apparently healthy, physically active males and females between 18-40 years of age with regular (minimum three times a week) resistance training experience for the last 6 months and regular caffeine intake (at least once a day).
Who cannot join
- recent musculoskeletal or musculotendinous injuries
Trial locations and contacts
1 site in 1 country.
Canada1 site
Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, A1C 5S7
About this study
Official title: The Effect of Acute Caffeine and Sodium Bicarbonate Supplementation on Upper and Lower Submaximal Resistance Training Performance
This research aims to explore the effects of two supplements, caffeine and sodium bicarbonate, on acute (short-term) resistance training performance. The present study aims to assess the effects of caffeine and sodium bicarbonate supplementation on the number of repetitions, muscle activation, speed of movement, and fatigue during resistance training.
Read the detailed description
The study will employ a randomized, double-blind, placebo-controlled, cross-over study design that examines the effect of caffeine and sodium bicarbonate on knee extension and bench press performance. Parameters include peak isoinertial force (1 repetition maximum: 1RM), rate of force development, movement velocity, number of repetitions to failure with a 10 repetition maximum (10RM) load, and electromyography (EMG) activity. The participants will complete three separate visits to the laboratory (1. placebo, 2. caffeine, and 3. sodium bicarbonate ingestion). With respect to the first visit, participants will sign a consent form and complete a health history questionnaire. Their respective anthropometric measurements will be taken, including height, weight, body mass index (BMI). Participants will then be introduced to the rate of perceived exertion scale for use during the trials. Blood lactate (Lactate Pro, Arkray, Kyoto, Japan) levels will be collected and analyzed from the index finger of the tested arm. Researchers will establish the 1RM for the bench press (upper-body) and knee extension (lower-body) exercises. The participants will complete a warm-up set of 8-10 repetitions at 50% of their body mass, followed by a 60-second rest period. The participants will then complete a second warm-up set of 3-5 repetitions with a 5-10 kg increase from the initial set, followed by another 60-second rest interval. the participants will then complete 2-3 repetitions with an additional 5-10 kg increase, followed by a rest for an additional 120 seconds. Each subsequent one-repetition attempt increased an additional 5-10 kg, followed by a 120-second rest period. The final attempt will be determined by repeating the steps illustrated above until the participants can no longer complete a single unassisted repetition with additional weight. This value will then be illustrated as the participant's 1RM and will be utilized to calculate exercise intensity for the two subsequent supplementation trials.
All testing will be performed within the laboratory. Participants are instructed to meet the following conditions 24-h before each experimental trial: (i) to avoid vigorous exercise, (ii) to adopt a similar diet and drink intake, (iii) to refrain from the consumption of alcohol, caffeine, and other stimulants.
Measures
For the knee extension measures, EMG activity will be collected from the mid-belly (midway between the anterior superior iliac spine to the superior edge of the patella) of the vastus lateralis and biceps femoris (midway between the gluteal fold and the popliteal space) of the non-dominant leg. Before participants perform the bench press, surface EMG recording electrodes will be placed approximately 3 cm apart over the proximal, lateral segment of the biceps brachii and over the lateral head of the triceps brachii. The distance of the biceps brachii electrodes from the acromion process and the distance of the triceps electrodes from the biceps electrodes will be recorded to ensure accurate replacement for subsequent tests. A thorough skin preparation for all electrodes will include shaving and removal of dead epithelial cells with abrasive pad around the designated areas, followed by cleansing with an isopropyl alcohol swab. EMG will be collected using a Biopac (Biopac Systems Inc.) data acquisition system at a sample rate of 2,000 Hz [impedance = 2 MΩ, common mode rejection ratio >110 dB min (50/60 Hz), noise >5 μV]. A bandpass filter (10-500 Hz) will be applied prior to digital conversion.
The root mean square (RMS) EMG will be monitored throughout the range of movements for both the bench press and knee extension. The mean RMS EMG will be normalized to the highest pre-test value and reported as a percentage.
A linear position transducer (Chronojump; Boscosystem, Barcelona, Spain) will be attached to the barbell to measure the excursion of the movement, time, and velocity. This device has been previously validated for velocity and power measurements.
Blood lactate levels will be measured with StatStrip Xpress Lactate (SSX) (Nova Biomedical, Waltham, Massachusetts, USA) prior to, during, and after the bench press and knee extension exercises to determine blood-lactate levels of the participants.
The participant's heart rate and rating of perceived exertion will be collected immediately after the completion of each set.
Intervention
During the subsequent three visits, participants will consume the placebo (dextrose), caffeine or sodium bicarbonate. A one week washout period will be allocated between visits. The same quantity will be used during both testing trials to ensure that the supplement is the only variable. The participants will spend 1 hour in a seated resting position after consuming the placebo or supplement. Participants will then utilize the same warm-up as the first visit, 8-10 repetitions at 50% of their body mass.
Testing Procedure
Using a 10RM load, participants will be instructed to complete as many repetitions as possible for each set (6 sets for each exercise) until they can no longer complete a repetition without assistance. Researchers will then record the number of repetitions participants complete during each set. The participant will then undergo a 60-second rest period between each set. After the participant completes the first exercise (e.g., six bench press or knee extension sets), they will undergo a 120-second rest period before beginning the same procedure on the next exercise (i.e., bench press or isoinertial knee extension resistance device). The order of bench press and knee extension exercises will be randomized.
- Conditions
- Nutritional Supplementation, Resistance Training
- Being tested
- Supplements
- Keywords
- caffeine, sodium bicarbonate, strength, fatigue, resistance training
- Medical subject headings
- Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SupplementsDietary supplement
Supplements provided to subjects 2 hours prior to testing and drank at 2 hours, 90 minutes and 45 minutes before testing.
| Study group | Role | What they receive |
|---|---|---|
| Caffeine | Experimental | Caffeine supplement is consumed at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of a caffeine and water solution at each time for a total consumed volume of 900mL .
Caffeine concentration - 3mg/kg or 0.003g/kg
Each solution has MiO Liquid Water Enhancer to mask the taste. Receives: Dietary Supplement: Supplements |
| Sodium bicarbonate | Experimental | Sodium bicarbonate supplement is consumed at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of sodium bicarbonate solution at each time for a total consumed volume of 900mL.
Sodium bicarbonate concentration - 0.3g/kg (Arm and Hammer brand)
Each solution has MiO Liquid Water Enhancer to mask the taste. Receives: Dietary Supplement: Supplements |
| Control | Sham comparator | Control solution is MiO + 300mL water at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of control solution at each time for a total consumed volume of 900mL. Receives: Dietary Supplement: Supplements |
What is being measured
The primary outcome is the main question the study is designed to answer.
Bench press repetitions to failure
During familiarization participants 12 repetition maximum was calculated. After drinking supplement or control participants perform 6 sets of 12 repetition bench press maximum repetitions to failure.
Outcome measure is the number of repetitions completed in each set of the 6 sets.
Measured: 45 minutes after last consumption of supplement or control drink solution.Order of bench press vs. knee extension is randomized.
Knee extensions repetitions to failure
During familiarization participants 12 repetition maximum was calculated. After drinking supplement or control participants perform 6 sets of 12 knee extension maximum repetitions to failure.
Outcome measure is the number of repetitions completed in each of the 6 sets.
Measured: 45 minutes after last consumption of supplement or control drink solution. Order of bench press vs. knee extension is randomized.
Secondary outcomes (4)
Blood lactate
Blood lactate obtained from index finger. Outcome measure is the millimoles of blood lactate at each testing time.
Measured: Pre- (1 minute prior to ingestion of supplement solution) and post-tests (1 minute after each bout of bench press and knee extensions to failure). Each measure should take 5 seconds.
Heart rate
Heart rate detected by heart rate monitor instantaneously Outcome measure is the heart rate reported in beats per minute at each testing time.
Measured: Heart rate (instantaneous feedback by monitor) will be recorded 10 seconds after every bench press and knee extension set in each condition/session (caffeine, sodium bicarbonate and control sessions).
Rating of perceived exertion
Adapted Borg scale with scale from 1-10. Reporting should take 2 seconds upon each request by the investigator.
Outcome measure is the participant's reported scale number at each testing time.
Measured: Recorded 20 seconds (response time = 2 seconds) after every bench press and knee extension set in each condition/session (caffeine, sodium bicarbonate and control sessions).
Electromyography (EMG) root mean square (Mean amplitude)
Surface EMG electrodes will be used to monitor muscle activation with every set of resistance training. The mean amplitude of the root mean square (RMS) of the EMG will be measured over the duration of each repetition. Filtering (band pass 5-500 Hz) and amplification (1000X) of the signal will be processed through a BioPac AcqKnowledge software system.
Measured: During every repetition to failure sets. Each set will take a maximum of 30 seconds. With fatigue from the repetitive 6 sets, the exercise and monitoring time will decrease.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Dec 2024
- Study start1 Aug 2024
- Primary completion5 Apr 2025
- Study completion5 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nutritional SupplementationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Early Phase 1
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- randomized, double-blind, placebo-controlled, cross-over study design with 1 intervention (supplements) with 3 arms (caffeine, sodium bicarbonate, control placebo).
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 12 participants (actual)
Sponsor and investigators
- Lead sponsor
- Memorial University of Newfoundland
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, David George Behm, Memorial University of Newfoundland
- Investigators
- David G Behm, PhD, Principal investigator, Memorial University of Newfoundland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06714331
- Sponsor's protocol ID
- 20241611
- Status last verified
- Feb 2026
- First submitted
- 1 Aug 2024
- Last updated
- 17 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will be available upon request to the individual. Anonymized data of the group will be available as supplementary material upon submission to a journal.
Study at a glance
From the registry record, last updated by the sponsor on 17 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Acute Caffeine and Sodium Bicarbonate Supplementation on Upper and Lower Submaximal Resistance Training Performance
- ClinicalTrials.gov ID
- NCT06714331
- Acronym / sponsor ID
- 20241611
- Conditions
- Nutritional Supplementation, Resistance Training
- Keywords
- caffeine, sodium bicarbonate, strength, fatigue, resistance training
- Phase
- Early Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 12 participants (actual)
- Lead sponsor
- Memorial University of NewfoundlandUniversity, hospital or other
- Study start
- 1 Aug 2024 (actual)
- Primary completion
- 5 Apr 2025 (actual)
- Study completion
- 5 May 2025 (actual)
- First posted
- 3 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research aims to explore the effects of two supplements, caffeine and sodium bicarbonate, on acute (short-term) resistance training performance. The present study aims to assess the effects of caffeine and sodium bicarbonate supplementation on the number of repetitions, muscle activation, speed of movement, and fatigue during resistance training.
Detailed description
The study will employ a randomized, double-blind, placebo-controlled, cross-over study design that examines the effect of caffeine and sodium bicarbonate on knee extension and bench press performance. Parameters include peak isoinertial force (1 repetition maximum: 1RM), rate of force development, movement velocity, number of repetitions to failure with a 10 repetition maximum (10RM) load, and electromyography (EMG) activity. The participants will complete three separate visits to the laboratory (1. placebo, 2. caffeine, and 3. sodium bicarbonate ingestion). With respect to the first visit, participants will sign a consent form and complete a health history questionnaire. Their respective anthropometric measurements will be taken, including height, weight, body mass index (BMI). Participants will then be introduced to the rate of perceived exertion scale for use during the trials. Blood lactate (Lactate Pro, Arkray, Kyoto, Japan) levels will be collected and analyzed from the index finger of the tested arm. Researchers will establish the 1RM for the bench press (upper-body) and knee extension (lower-body) exercises. The participants will complete a warm-up set of 8-10 repetitions at 50% of their body mass, followed by a 60-second rest period. The participants will then complete a second warm-up set of 3-5 repetitions with a 5-10 kg increase from the initial set, followed by another 60-second rest interval. the participants will then complete 2-3 repetitions with an additional 5-10 kg increase, followed by a rest for an additional 120 seconds. Each subsequent one-repetition attempt increased an additional 5-10 kg, followed by a 120-second rest period. The final attempt will be determined by repeating the steps illustrated above until the participants can no longer complete a single unassisted repetition with additional weight. This value will then be illustrated as the participant's 1RM and will be utilized to calculate exercise intensity for the two subsequent supplementation trials.
All testing will be performed within the laboratory. Participants are instructed to meet the following conditions 24-h before each experimental trial: (i) to avoid vigorous exercise, (ii) to adopt a similar diet and drink intake, (iii) to refrain from the consumption of alcohol, caffeine, and other stimulants.
Measures
For the knee extension measures, EMG activity will be collected from the mid-belly (midway between the anterior superior iliac spine to the superior edge of the patella) of the vastus lateralis and biceps femoris (midway between the gluteal fold and the popliteal space) of the non-dominant leg. Before participants perform the bench press, surface EMG recording electrodes will be placed approximately 3 cm apart over the proximal, lateral segment of the biceps brachii and over the lateral head of the triceps brachii. The distance of the biceps brachii electrodes from the acromion process and the distance of the triceps electrodes from the biceps electrodes will be recorded to ensure accurate replacement for subsequent tests. A thorough skin preparation for all electrodes will include shaving and removal of dead epithelial cells with abrasive pad around the designated areas, followed by cleansing with an isopropyl alcohol swab. EMG will be collected using a Biopac (Biopac Systems Inc.) data acquisition system at a sample rate of 2,000 Hz [impedance = 2 MΩ, common mode rejection ratio >110 dB min (50/60 Hz), noise >5 μV]. A bandpass filter (10-500 Hz) will be applied prior to digital conversion.
The root mean square (RMS) EMG will be monitored throughout the range of movements for both the bench press and knee extension. The mean RMS EMG will be normalized to the highest pre-test value and reported as a percentage.
A linear position transducer (Chronojump; Boscosystem, Barcelona, Spain) will be attached to the barbell to measure the excursion of the movement, time, and velocity. This device has been previously validated for velocity and power measurements.
Blood lactate levels will be measured with StatStrip Xpress Lactate (SSX) (Nova Biomedical, Waltham, Massachusetts, USA) prior to, during, and after the bench press and knee extension exercises to determine blood-lactate levels of the participants.
The participant's heart rate and rating of perceived exertion will be collected immediately after the completion of each set.
Intervention
During the subsequent three visits, participants will consume the placebo (dextrose), caffeine or sodium bicarbonate. A one week washout period will be allocated between visits. The same quantity will be used during both testing trials to ensure that the supplement is the only variable. The participants will spend 1 hour in a seated resting position after consuming the placebo or supplement. Participants will then utilize the same warm-up as the first visit, 8-10 repetitions at 50% of their body mass.
Testing Procedure
Using a 10RM load, participants will be instructed to complete as many repetitions as possible for each set (6 sets for each exercise) until they can no longer complete a repetition without assistance. Researchers will then record the number of repetitions participants complete during each set. The participant will then undergo a 60-second rest period between each set. After the participant completes the first exercise (e.g., six bench press or knee extension sets), they will undergo a 120-second rest period before beginning the same procedure on the next exercise (i.e., bench press or isoinertial knee extension resistance device). The order of bench press and knee extension exercises will be randomized.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 3
- Model description
- randomized, double-blind, placebo-controlled, cross-over study design with 1 intervention (supplements) with 3 arms (caffeine, sodium bicarbonate, control placebo).
| Arm | Type | Receives |
|---|---|---|
| Caffeine | Experimental | Dietary Supplement: SupplementsCaffeine supplement is consumed at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of a caffeine and water solution at each time for a total consumed volume of 900mL . Caffeine concentration - 3mg/kg or 0.003g/kg Each solution has MiO Liquid Water Enhancer to mask the taste. |
| Sodium bicarbonate | Experimental | Dietary Supplement: SupplementsSodium bicarbonate supplement is consumed at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of sodium bicarbonate solution at each time for a total consumed volume of 900mL. Sodium bicarbonate concentration - 0.3g/kg (Arm and Hammer brand) Each solution has MiO Liquid Water Enhancer to mask the taste. |
| Control | Sham comparator | Dietary Supplement: SupplementsControl solution is MiO + 300mL water at 3 time points (120, 90 and 45 minutes prior to testing) with participants drinking 300mL of control solution at each time for a total consumed volume of 900mL. |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- apparently healthy, physically active males and females between 18-40 years of age with regular (minimum three times a week) resistance training experience for the last 6 months and regular caffeine intake (at least once a day).
Key exclusion criteria (1 listed)
- recent musculoskeletal or musculotendinous injuries
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SupplementsSupplements provided to subjects 2 hours prior to testing and drank at 2 hours, 90 minutes and 45 minutes before testing. | Dietary supplement | Caffeine, Control, Sodium bicarbonate |
Primary outcome
Bench press repetitions to failure
Time frame: 45 minutes after last consumption of supplement or control drink solution.Order of bench press vs. knee extension is randomized.
During familiarization participants 12 repetition maximum was calculated. After drinking supplement or control participants perform 6 sets of 12 repetition bench press maximum repetitions to failure. Outcome measure is the number of repetitions completed in each set of the 6 sets.
Knee extensions repetitions to failure
Time frame: 45 minutes after last consumption of supplement or control drink solution. Order of bench press vs. knee extension is randomized.
During familiarization participants 12 repetition maximum was calculated. After drinking supplement or control participants perform 6 sets of 12 knee extension maximum repetitions to failure. Outcome measure is the number of repetitions completed in each of the 6 sets.
4 secondary outcomes
Blood lactate
Time frame: Pre- (1 minute prior to ingestion of supplement solution) and post-tests (1 minute after each bout of bench press and knee extensions to failure). Each measure should take 5 seconds.
Heart rate
Time frame: Heart rate (instantaneous feedback by monitor) will be recorded 10 seconds after every bench press and knee extension set in each condition/session (caffeine, sodium bicarbonate and control sessions).
Rating of perceived exertion
Time frame: Recorded 20 seconds (response time = 2 seconds) after every bench press and knee extension set in each condition/session (caffeine, sodium bicarbonate and control sessions).
Electromyography (EMG) root mean square (Mean amplitude)
Time frame: During every repetition to failure sets. Each set will take a maximum of 30 seconds. With fatigue from the repetitive 6 sets, the exercise and monitoring time will decrease.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Feb 2026.
- Individual participant dataSharing planned: No. Individual participant data will be available upon request to the individual. Anonymized data of the group will be available as supplementary material upon submission to a journal.
Related trials for Nutritional Supplementation
Not yet recruiting
Effects of Daily Magnesium Complex Supplementation on Body Composition in University Students
Body Composition Changes, Muscle Mass
Not yet recruiting
Effect of Vitamin D Supplementation Added to Iron Therapy in Children With Iron Deficiency Anemia
Iron Deficiency Anemia
Not yet recruitingPhase 2
Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia
Pediatric Chalazia
Not yet recruiting
Effect of Propionic Acid Supplementation on Endothelial Function
Cardiovascular Diseases, Endothelial Dysfunction
Recruiting
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
Healthy Volunteer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David G Behm, PhD principal investigator
Memorial University of Newfoundland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Early Phase 1 study testing Supplements in people with Nutritional Supplementation and Resistance Training, run by Memorial University of Newfoundland at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Bench press repetitions to failure (time frame: 45 minutes after last consumption of supplement or control drink solution.Order of bench press vs. knee extension is randomized.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.